These mutations accord approximately in 40% of HR+ BC, mainly in the helical and kinase domains of the PIK3CA gene, including three main hotspot mutations: exon 9 E545K or E542K and exon 20 H1047R [21]. Here, PIK3CA is linked to breast cancer.